“We welcome the approval of VEOZA, a first-of-its-kind non-hormonal treatment option based on the biology behind hot flushes,” said Christine Kemp, senior medical lead at Astellas Australia.
Astellas Pharma welcomes approval of first-of-its-kind non-hormonal treatment
April 5, 2024 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
New Zealand moves again to make it easier to access medicines
July 11, 2025 - - Latest News -
The 'Dispatched' Week in Review Podcast - 10 July
July 10, 2025 - - Podcast -
'The debate is frustrating but it is an opportunity to amplify acknowledged concerns'
July 10, 2025 - - Latest News -
Medibank to subsidise pharmacogenetic testing for members
July 10, 2025 - - Latest News -
Is this the missing link in pharma engagement strategies?
July 9, 2025 - - Latest News -
Stakeholders welcome medicinal cannabis crackdown
July 9, 2025 - - Latest News -
Might Australia be just a little hypocritical on pharmaceutical tariffs?
July 9, 2025 - - Latest News